Testing effectiveness (Phase 2)Active Not RecruitingNCT06157099
What this trial is testing
Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma
Who this might be right for
Pathologic Stage IIIA Cutaneous Melanoma AJCC v8Pathologic Stage IIA Cutaneous Melanoma AJCC v8Pathologic Stage IIB Cutaneous Melanoma AJCC v8
OHSU Knight Cancer Institute 150